Table of Contents
What Is Myoclonic Epilepsy With Ragged-Red Fibers?
Myoclonic epilepsy with ragged-red fibers (MERRF) is a multisystem disorder characterized by involvement of the nervous system and muscles in particular. Typically, this disorder manifests its signs and symptoms during the period of infancy or adolescence. MERRF is distinguished by progressive rigidity (spasticity), weakness (myopathy), and muscle spasms (myoclonus). Typically, muscle cells from affected individuals exhibit an anomalous appearance when stained and examined under a microscope. The term for these atypical muscle cells is "ragged-red fibers." Epilepsy (recurrent seizures), ataxia (difficulty coordinating movements), peripheral neuropathy (sensory loss in the extremities), and dementia (gradual decline in neural function) are additional characteristics of MERRF. Additionally, optic atrophy, which is the degeneration of nerve cells responsible for transmitting visual information from the eyes to the brain, and hearing loss may develop in individuals with this condition. Acute individuals may also present with cardiomyopathy, a form of heart disease characterized by short stature. Less frequently, individuals with MERRF develop subcutaneous lipomas, which are fatty tumors.
What Are the Causes?
MT-TK gene mutations account for over 80 percent of all MERRF instances and are the most frequent cause. MT-TL1, MT-TH, and MT-TS1 gene mutations have reportedly been observed to be less commonly responsible for the symptoms and signs of MERRF. The indications and symptoms of MERRF are frequently present in individuals with abnormalities in the MT-TL1, MT-TH, or MT-TS1 genes, as well as those of other mitochondrial illnesses.
In mitochondrial DNA (mtDNA), there are four genes: MT-TK, MT-TL1, MT-TH, and MT-TS1. Through a process known as oxidative phosphorylation, mitochondria, which are parts of cells, use oxygen to transform food energy into a form that can be utilized by cells. A minor quantity of mitochondrial DNA exists, even though most DNA is contained in chromosomes inside the nucleus. Making transfer RNAs chemically related to DNA is guided by the instructions provided by the genes linked to MERRF. Within mitochondria, these molecules aid in synthesizing complete, functional proteins from amino acids, the basic building blocks of proteins. These proteins carry out oxidative phosphorylation.
The production of proteins, the utilization of oxygen, and energy production by mitochondria are all hampered by MERRF mutations. Particular organs and tissues affected by these abnormalities include the brain and muscles, which have high energy requirements. Researchers have not yet identified the precise symptoms and indicators of MERRF due to alterations in mtDNA.
Mutations in other mitochondrial genes bring on a few cases of MERRF; in other cases, the ailment's exact source is unknown.
What Is the Diagnostic Method?
-
Laboratory Testing: Lactic acid levels are typically elevated in both the blood and cerebrospinal fluid (CSF) of symptomatic and asymptomatic MERRF patients. After physical activity and exercise, lactic acid levels are further elevated. The CSF protein level is also elevated but rarely exceeds 100 mg/dl. CK elevation is frequently indicative of myopathy. In addition, it is essential to rule out other treatable conditions which could mimic mitochondrial disease. Among these are autoimmune inflammatory disorders, endocrinopathies (diabetes, adrenal, thyroid, and parathyroid disorders), vitamin B12 deficiency, and collagen formation disorders.
-
Imaging: Brain scans using magnetic resonance imaging (MRI) and computed tomography (CT) may reveal early gray matter changes, whereas white matter changes occur late in the disease. Other imaging characteristics of MERRF include cerebral atrophy, cerebellar atrophy in calcification of the dentate nucleus, and alterations in the red nucleus due to progressive neuronal loss. Magnetic resonance spectroscopy (MRS) can prove useful In diagnosing MERRF. It displays a significant lactic acid peak.
-
Evaluation of Electrophysiology: Electroencephalogram (EEG) can indicate a sluggish background activity accompanied by generalized epileptiform discharges that may be triggered by photic stimulation. These EEG characteristics may also be observed in the progress of MELAS and other myoclonic epilepsies. Electromyography and nerve conduction studies can identify small polyphasic motor units in early recruitment, indicative of a myopathic process. Nevertheless, some patients may exhibit concomitant neuropathy.
-
Muscle Tissue Biopsy: A muscle biopsy is performed to diagnose disorders that affect muscle tissue. Following removing tissue and cells from a particular muscle, the healthcare provider will examine these specimens under a microscope. A muscle biopsy is essential for diagnosing mitochondrial disorders like MERRF. More than ninety percent of individuals with MERRF exhibit pathognomonic red fibers with frayed edges.
-
Genetic Analysis: The examination of a sample of DNA to seek for changes, sometimes known as variants, that may raise an individual's risk for disease or alter treatment reactions is referred to as genetic analysis. This phrase is used to describe the process of analyzing a DNA sample. MERRF is a condition that can be identified by genetic testing. If a mutation is discovered in a family, DNA testing may be taken to determine which family members are in danger.
What Are the Treatment Methods?
MERRF is similar to other mitochondrial illnesses in that no specific medication is available for it, as no treatment is available for this illness.
-
Several different treatment drugs are tested in an attempt to slow down the decline's progression, with varying degrees of success.
-
In patients with MERRF, the most important aspect of treatment is the symptomatic care of any problems. Patients suffering from epilepsy or myoclonic seizures are typically prescribed antiepileptic medication. Sodium valproate is normally the treatment of choice for treating myoclonic epilepsies; however, it must be used with extreme caution for treating mitochondrial illnesses because it has the potential to trigger liver failure.
-
Treatment for additional complications, including rhythm problems with heart deafness, is determined by their degree of severity.
-
It is critical to avoid substances and medications that can potentially damage mitochondria, including alcohol and antibiotics.
What Are the Complications?
Individuals who suffer from MERRF have a higher risk of cardiac arrhythmia (malfunctioning of the electrical signals responsible for regulating the heartbeat) as well as ventricular dysfunction (impaired or abnormal functioning of the ventricles, which are the lower chambers of the heart responsible for pumping blood to the rest of the body), both of which can lead to cardiac failure and unexpected death. They also have a high chance of getting a head injury that causes seizures, breathing problems, a spinal disorder, diabetes, and problems with their thyroids.
Conclusion
Myoclonic epilepsy with ragged-red fibers is a hereditary condition characterized by myoclonic epilepsy, cerebellar ataxia, and increasing muscle weakening. An examination of the brain would reveal intact cranial nerves, diminished deep tendon reflexes, and decreased feeling of touch, pain, and vibration. The biopsy of the muscle revealed ragged-red fibers. As a result, imaging investigations and follow-up exams are critical in individuals with myoclonic epilepsy.
